302 related articles for article (PubMed ID: 28407670)
1. Methylglyoxal and Advanced Glycation End Products in Patients with Diabetes - What We Know so Far and the Missing Links.
Groener JB; Oikonomou D; Cheko R; Kender Z; Zemva J; Kihm L; Muckenthaler M; Peters V; Fleming T; Kopf S; Nawroth PP
Exp Clin Endocrinol Diabetes; 2019 Sep; 127(8):497-504. PubMed ID: 28407670
[TBL] [Abstract][Full Text] [Related]
2. Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.
Brings S; Fleming T; Freichel M; Muckenthaler MU; Herzig S; Nawroth PP
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475116
[TBL] [Abstract][Full Text] [Related]
3. Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer.
Bellier J; Nokin MJ; Lardé E; Karoyan P; Peulen O; Castronovo V; Bellahcène A
Diabetes Res Clin Pract; 2019 Feb; 148():200-211. PubMed ID: 30664892
[TBL] [Abstract][Full Text] [Related]
4. Glycotoxines, carbonyl stress and relevance to diabetes and its complications.
Turk Z
Physiol Res; 2010; 59(2):147-156. PubMed ID: 19537931
[TBL] [Abstract][Full Text] [Related]
5. Methylglyoxal, diabetes mellitus and diabetic complications.
Vander Jagt DL
Drug Metabol Drug Interact; 2008; 23(1-2):93-124. PubMed ID: 18533366
[TBL] [Abstract][Full Text] [Related]
6. Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises.
Matafome P; Rodrigues T; Sena C; Seiça R
Med Res Rev; 2017 Mar; 37(2):368-403. PubMed ID: 27636890
[TBL] [Abstract][Full Text] [Related]
7. Skin fluorescence as a clinical tool for non-invasive assessment of advanced glycation and long-term complications of diabetes.
Fokkens BT; Smit AJ
Glycoconj J; 2016 Aug; 33(4):527-35. PubMed ID: 27287226
[TBL] [Abstract][Full Text] [Related]
8. Dicarbonyls Generation, Toxicities, Detoxifications and Potential Roles in Diabetes Complications.
Alouffi S; Khan MWA
Curr Protein Pept Sci; 2020; 21(9):890-898. PubMed ID: 31660813
[TBL] [Abstract][Full Text] [Related]
9. [The role of methylglyoxal metabolism in type-2 diabetes and its complications].
Kender Z; Torzsa P; Grolmusz K V; Patócs A; Lichthammer A; Veresné Bálint M; Rácz K; Reismann P
Orv Hetil; 2012 Apr; 153(15):574-85. PubMed ID: 22472358
[TBL] [Abstract][Full Text] [Related]
10. Nanoindentation time-dependent deformation/recovery suggestive of methylglyoxal induced glycation in calcified nodules.
Rodriguez R; Yoshimura K; Shibata Y; Miyamoto Y; Tanaka R; Uyama R; Sasa K; Suzuki D; Miyazaki T; Kamijo R
Nanomedicine; 2017 Nov; 13(8):2545-2553. PubMed ID: 28754466
[TBL] [Abstract][Full Text] [Related]
11. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.
Genuth S; Sun W; Cleary P; Gao X; Sell DR; Lachin J; ; Monnier VM
Diabetes; 2015 Jan; 64(1):266-78. PubMed ID: 25187362
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products and diabetic complications: a general overview.
Peppa M; Vlassara H
Hormones (Athens); 2005; 4(1):28-37. PubMed ID: 16574629
[TBL] [Abstract][Full Text] [Related]
13. (+)-Catechin mitigates impairment in insulin secretion and beta cell damage in methylglyoxal-induced pancreatic beta cells.
Anaga N; Lekshmy K; Purushothaman J
Mol Biol Rep; 2024 Mar; 51(1):434. PubMed ID: 38520585
[TBL] [Abstract][Full Text] [Related]
14. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes.
Yang P; Feng J; Peng Q; Liu X; Fan Z
Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827
[TBL] [Abstract][Full Text] [Related]
15. [The glucose, glycotoxins and glycation products: the involvement into pathogenesis of microangiopathies, arteriolosclerosis and atherosclerosis].
Titov VN; Shiriaeva IuK
Klin Lab Diagn; 2011 Nov; (11):3-13. PubMed ID: 22312908
[TBL] [Abstract][Full Text] [Related]
16. Contribution of methylglyoxal to delayed healing of bone injury in diabetes.
Aikawa T; Matsubara H; Ugaji S; Shirakawa J; Nagai R; Munesue S; Harashima A; Yamamoto Y; Tsuchiya H
Mol Med Rep; 2017 Jul; 16(1):403-409. PubMed ID: 28534951
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation: a novel outlook on atherosclerosis.
Price CL; Knight SC
Curr Pharm Des; 2007; 13(36):3681-7. PubMed ID: 18220806
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycosylation end products in skin, serum, saliva and urine and its association with complications of patients with type 2 diabetes mellitus.
Garay-Sevilla ME; Regalado JC; Malacara JM; Nava LE; Wróbel-Zasada K; Castro-Rivas A; Wróbel K
J Endocrinol Invest; 2005 Mar; 28(3):223-30. PubMed ID: 15952406
[TBL] [Abstract][Full Text] [Related]
19. Methylglyoxal-derived hydroimidazolone-1 evokes inflammatory reactions in endothelial cells via an interaction with receptor for advanced glycation end products.
Ishibashi Y; Matsui T; Nakamura N; Sotokawauchi A; Higashimoto Y; Yamagishi SI
Diab Vasc Dis Res; 2017 Sep; 14(5):450-453. PubMed ID: 28631505
[TBL] [Abstract][Full Text] [Related]
20. Metformin inhibition of glycation processes.
Beisswenger P; Ruggiero-Lopez D
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S95-103. PubMed ID: 14502106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
